Increased serum levels of advanced glycation end-products is associated with severity of sleep disordered breathing but not insulin sensitivity in non-diabetic men with obstructive sleep apnoea
Increased serum levels of advanced glycation end-products is associated with severity of sleep disordered breathing but not insulin sensitivity in non-diabetic men with obstructive sleep apnoea
复制标题
DOI:
10.1016/j.sleep.2011.07.015
复制
发表时间:
2012-01-01
期刊:
影响因子:
4.8
通讯作者:
Ip, Mary S. M.
中科院分区:
文献类型:
--
作者:
Lam, Jamie C. M.;Tan, Kathryn C. B.;Ip, Mary S. M.
Background: Patients with diabetes mellitus are known to have increased serum levels of advanced glycation end-products (AGEs), and this is also associated with insulin resistance. This study aimed to investigate the relationship between serum AGEs and insulin sensitivity in non-diabetic subjects with obstructive sleep apnoea (OSA).Methods: Adult males with no known comorbidities were recruited from the sleep clinic of a university teaching hospital. They underwent overnight in-laboratory polysomnography. Fasting blood was taken to measure serum AGE and plasma glucose levels. Insulin sensitivity was estimated using the short insulin tolerance test.Results: In total, 105 subjects with a mean age of 43.5 (standard deviation [SD] 9.2) years, mean body mass index of 27.1 (SD 4.0) kg/m(2), and median apnoea-hypopnoea index (AHI) of 17 (interquartile range 5-46) were analysed. Serum AGE levels were significantly higher in subjects with OSA (AHI >= 5), compared with those without OSA (AHI